REHZILIS
Live / Allowed — Approved for publication (as of 29 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99431689
- Mark type
- Stylized text
- Filed
- 07 Oct 2025
- Attorney of record
- Neha Bhalani
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations targeting the HER2 protein for the treatment of cancer; Immunotherapy pharmaceutical preparations targeting the HER2 protein for the treatment of cancer; vaccine preparations targeting the HER2 protein for the treatment of cancer
Owner
- OS Therapies Inc., Grasonville, MD, US
Prosecution history
- 29 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Feb 2026 — NON-FINAL ACTION E-MAILED
- 25 Feb 2026 — NON-FINAL ACTION WRITTEN
- 25 Feb 2026 — ASSIGNED TO EXAMINER
- 07 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 07 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Oct 2025 — NEW APPLICATION ENTERED